No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US ETFDetailed Quotes
CNCR Loncar Cancer Immunotherapy ETF
- 12.090
- +0.122+1.02%
Close Dec 20 16:00 ET
12.210High11.870Low
12.210High11.870Low2.51KVolume11.870Open11.968Pre Close30.29KTurnover0.30%Turnover Ratio--P/E (Static)830.81KShares17.96052wk High--P/B10.04MFloat Cap11.86052wk Low--Dividend TTM830.81KShs Float33.280Historical High--Div YieldTTM2.84%Amplitude9.220Historical Low12.083Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
J.P. Morgan's Top Healthcare Stocks for 2025
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Wells Fargo Maintains Equal-Weight on Zymeworks, Raises Price Target to $14
Wells Fargo Downgrades Monte Rosa Therapeutics to Equal-Weight, Lowers Price Target to $11
Monte Rosa Therapeutics Analyst Ratings
BioArctic Partners With Bristol Myers Squibb In Licensing Deal For PyroGlutamate-Amyloid-Beta Antibody Program